pCMV-MMLVgag-3xNES-Cas9 Citations (2)

Originally described in: Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins.
Banskota S, Raguram A, Suh S, Du SW, Davis JR, Choi EH, Wang X, Nielsen SC, Newby GA, Randolph PB, Osborn MJ, Musunuru K, Palczewski K, Liu DR Cell. 2022 Jan 7. pii: S0092-8674(21)01484-7. doi: 10.1016/j.cell.2021.12.021. PubMed Journal

Articles Citing pCMV-MMLVgag-3xNES-Cas9

Showing 1 to 2 of 2 entries

Show entries

Search table:

Articles
Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPs. Wichmann M, Maire CL, Nuppenau N, Habiballa M, Uhde A, Kolbe K, Schroder T, Lamszus K, Fehse B, Glow D. Int J Mol Sci. 2023 Jul 13;24(14):11399. doi: 10.3390/ijms241411399. PubMed
Prediction of efficiencies for diverse prime editing systems in multiple cell types. Yu G, Kim HK, Park J, Kwak H, Cheong Y, Kim D, Kim J, Kim J, Kim HH. Cell. 2023 Apr 21:S0092-8674(23)00331-8. doi: 10.1016/j.cell.2023.03.034. PubMed Associated Plasmids pLenti-NRCH-PE2-BSD pLenti-PE2max-BSD pLenti-NRCH-PE2max-BSD pLenti-EF1a-hMLH1dn-eGFP pLenti_gRNA -hMLHdn-Puro More ...

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.